Table 1 Demographics and comorbidities – comparison between survivors and non-survivors
From: Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study
Total (n = 236) | Survivors (n = 183) | Non-Survivors (n = 53) | p value | |
|---|---|---|---|---|
f (%) | f (%) | f (%) | ||
Age (years) | ||||
10–19 | 5 (2.12) | 5 (2.73) | 0 (0) | 0.025 |
20–29 | 21 (8.9) | 20 (10.93) | 1 (1.89) | < 0.001 |
30–39 | 27 (11.44) | 25 (13.66) | 2 (3.77) | < 0.001 |
40–49 | 43 (18.22) | 37 (20.22) | 6 (11.32) | < 0.001 |
50–59 | 50 (21.19) | 43 (23.5) | 7 (13.21) | < 0.001 |
60–69 | 49 (20.76) | 32 (17.49) | 17 (32.08) | 0.032 |
70–79 | 29 (12.29) | 14 (7.65) | 15 (28.3) | 0.853 |
80–89 | 9 (3.81) | 6 (3.23) | 3 (5.66) | 0.317 |
90–99 | 3 (1.27) | 1 (0.55) | 2 (3.77) | 0.564 |
Total | 236 | 183 | 53 | |
Gender | ||||
Female | 141 (59.75) | 108 (59.02) | 33 (62.26) | < 0.001 |
Male | 95 (40.25) | 75 (40.98) | 20 (37.74) | < 0.001 |
Total | 236 | 183 | 53 | |
Race | ||||
Black African | 207 (87.71) | 163 (89.07) | 44 (83.02) | < 0.001 |
White | 8 (3.39) | 5 (2.73) | 3 (5.66) | 0.48 |
Coloured | 1 (0.42) | 1 (0.55) | 0 (0) | 0.317 |
Asian | 20 (8.47) | 14 (7.65) | 6 (11.32) | 0.074 |
Total | 236 | 183 | 53 | |
Comorbidities | ||||
Diabetes | 79 (33.47) | 58 (31.69) | 21 (39.62) | < 0.001 |
Hypertension | 95 (40.25) | 59 (32.24) | 36 (67.92) | 0.018 |
COPD/Asthma | 12 (5.08) | 9 (4.92) | 3 (5.66) | 0.083 |
HIV | 68 (28.81) | 56 (30.6) | 12 (22.64) | < 0.001 |